Definium director exercises options for 1,629 shares
Director Andreas Krebs fully exercised a 1,629-share stock option, increasing his direct holdings in DFTX to 21,402 common shares.
Rhea-AI Filing Summary
Definium Therapeutics, Inc. (DFTX) director Andreas Krebs exercised stock options covering 1,629 Common Shares on September 18, 2026, at an exercise price of $35.52 per share. The option position reported was fully exercised, and his direct holdings increased to 21,402 Common Shares. No Rule 10b5-1 trading plan is reported.
Positive
- None.
Negative
- None.
Insider Trade Summary
1,629 shares exercised/converted
Exercise
2 txns
Insider
Krebs Andreas
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Buy) | 1,629 | $0.00 | $0.00 |
| Exercise | Common Shares | 1,629 | $35.52 | $58K |
Holdings After Transaction:
Stock Option (Right to Buy) — 0 contracts (Direct);
Common Shares — 21,402 shares (Direct)
Key Figures
Options Exercised: 1,629 shares
Exercise Price: $35.52 per share
Shares Received: 1,629 Common Shares
+2 more
5 metrics
Options Exercised
1,629 shares
Stock option exercise on September 18, 2026
Exercise Price
$35.52 per share
Stock option (right to buy) converted into Common Shares
Shares Received
1,629 Common Shares
Result of option exercise reported as non-derivative acquisition
Holdings After Transaction
21,402 Common Shares
Direct ownership by Andreas Krebs following the exercise
Option Expiration Date
September 29, 2026
Expiration date of stock option that was exercised
Key Terms
Stock Option (Right to Buy), derivative security, Rule 10b5-1
3 terms
Stock Option (Right to Buy) financial
"security titled "Stock Option (Right to Buy)" was exercised"
derivative security financial
"described as an exercise or conversion of derivative security"
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
Rule 10b5-1 regulatory
"no Rule 10b5-1 plan is reported for these transactions"
Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did DFTX director Andreas Krebs report?
He reported exercising stock options into 1,629 Common Shares on September 18, 2026, at an exercise price of $35.52 per share, increasing his direct holdings to 21,402 Common Shares.
What was the exercise price of the DFTX stock options exercised by Andreas Krebs?
The stock options exercised by Andreas Krebs had an exercise price of $35.52 per share for 1,629 Common Shares.
Was the DFTX insider transaction under a Rule 10b5-1 trading plan?
The filing indicates no Rule 10b5-1 plan is reported; the document-level checkbox is not marked as being pursuant to a Rule 10b5-1 trading arrangement.
AI-generated analysis. How Rhea-AI works. Not financial advice.
